VERTICAL Trademark
Trademark Overview
On Tuesday, July 30, 2024, a trademark application was filed for VERTICAL with the United States Patent and Trademark Office. The USPTO has given the VERTICAL trademark a serial number of 98674143. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, April 14, 2026. This trademark is owned by Vertical Pharmaceuticals, LLC. The VERTICAL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Non-liquid pharmaceutical products and preparations for use in the treatment of wounds, as muscle relaxants, as multivitamin and/or mineral supplements, in pain management, as opioid analgesics, in the treatment of diseases and disorders of the central nervous system, in the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, as antibiotics, in the treatment of Parkinson's disease, in the treatment of Hyperkalemia, in the treatment of hyperammonemia, as pharmaceutical beta-blocker preparations and products, and as antidepressants, and non-liquid vitamin supplements and nutraceuticals for use as dietary supplements
Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development
General Information
| Serial Number | 98674143 |
| Word Mark | VERTICAL |
| Filing Date | Tuesday, July 30, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Non-liquid pharmaceutical products and preparations for use in the treatment of wounds, as muscle relaxants, as multivitamin and/or mineral supplements, in pain management, as opioid analgesics, in the treatment of diseases and disorders of the central nervous system, in the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, as antibiotics, in the treatment of Parkinson's disease, in the treatment of Hyperkalemia, in the treatment of hyperammonemia, as pharmaceutical beta-blocker preparations and products, and as antidepressants, and non-liquid vitamin supplements and nutraceuticals for use as dietary supplements |
| Goods and Services | Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, October 25, 2013 |
| First Use In Commerce Date | Friday, October 25, 2013 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 25, 2013 |
| First Use In Commerce Date | Friday, October 25, 2013 |
Trademark Owner History
| Party Name | Vertical Pharmaceuticals, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Alpharetta, GA 30005
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, July 30, 2024 | NEW APPLICATION ENTERED |
| Tuesday, July 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 6, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, February 12, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 12, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 12, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 12, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, May 12, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, June 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 14, 2026 | FINAL REFUSAL WRITTEN |
| Tuesday, April 14, 2026 | FINAL REFUSAL E-MAILED |
| Tuesday, April 14, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, May 27, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 27, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
